544 related articles for article (PubMed ID: 32603802)
1. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
Yang JW; Yang L; Luo RG; Xu JF
Clin Microbiol Infect; 2020 Sep; 26(9):1171-1177. PubMed ID: 32603802
[TBL] [Abstract][Full Text] [Related]
2. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids as adjunctive therapy in the treatment of influenza.
Lansbury L; Rodrigo C; Leonardi-Bee J; Nguyen-Van-Tam J; Lim WS
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD010406. PubMed ID: 30798570
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019.
Rafiullah M; Siddiqui K
J Comp Eff Res; 2020 Dec; 9(18):1247-1254. PubMed ID: 33245242
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and corticosteroids: a narrative review.
El-Saber Batiha G; Al-Gareeb AI; Saad HM; Al-Kuraishy HM
Inflammopharmacology; 2022 Aug; 30(4):1189-1205. PubMed ID: 35562628
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids as adjunctive therapy in the treatment of influenza.
Rodrigo C; Leonardi-Bee J; Nguyen-Van-Tam J; Lim WS
Cochrane Database Syst Rev; 2016 Mar; 3():CD010406. PubMed ID: 26950335
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Evidence for Corticosteroids in COVID-19.
Johns M; George S; Taburyanskaya M; Poon YK
J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
[TBL] [Abstract][Full Text] [Related]
10. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
Wang Y; Li W; Jiang Z; Xi X; Zhu Y
Medicine (Baltimore); 2020 Sep; 99(38):e22379. PubMed ID: 32957417
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Moreno G; Rodríguez A; Reyes LF; Gomez J; Sole-Violan J; Díaz E; Bodí M; Trefler S; Guardiola J; Yébenes JC; Soriano A; Garnacho-Montero J; Socias L; Del Valle Ortíz M; Correig E; Marín-Corral J; Vallverdú-Vidal M; Restrepo MI; Torres A; Martín-Loeches I;
Intensive Care Med; 2018 Sep; 44(9):1470-1482. PubMed ID: 30074052
[TBL] [Abstract][Full Text] [Related]
14. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
Yang Z; Liu J; Zhou Y; Zhao X; Zhao Q; Liu J
J Infect; 2020 Jul; 81(1):e13-e20. PubMed ID: 32283144
[TBL] [Abstract][Full Text] [Related]
15. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis.
Wang J; Yang W; Chen P; Guo J; Liu R; Wen P; Li K; Lu Y; Ma T; Li X; Qin S; Zhang Y; Wang Y
PLoS One; 2021; 16(4):e0249481. PubMed ID: 33882090
[TBL] [Abstract][Full Text] [Related]
16. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.
Ma Q; Qi D; Deng XY; Yuan GD; Tian WG; Cui Y; Yan XF; Wang DX
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8194-8201. PubMed ID: 32767349
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.
Saleki K; Yaribash S; Banazadeh M; Hajihosseinlou E; Gouravani M; Saghazadeh A; Rezaei N
Eur J Pharmacol; 2021 Sep; 906():174248. PubMed ID: 34126092
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
Liu W; Zhou P; Chen K; Ye Z; Liu F; Li X; He N; Wu Z; Zhang Q; Gong X; Tang Q; Du X; Ying Y; Xu X; Zhang Y; Liu J; Li Y; Shen N; Couban RJ; Ibrahim QI; Guyatt G; Zhai S
CMAJ; 2020 Jul; 192(27):E734-E744. PubMed ID: 32493740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
